XBRU
GIMB
Market cap1.88bUSD
Jun 18, Last price
44.65EUR
1D
-0.89%
1Q
2.29%
Jan 2017
-15.19%
Name
Gimv NV
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Gimv N.V. operates as an investment company, specializing in both direct private equity and venture capital placements, alongside committing capital to other funds. Its direct investment approach spans a comprehensive range of stages and financing structures. This includes supporting startups from seed, early, and mid-stages through to late venture and emerging growth, as well as engaging in pre-revenue, middle-market, and mature company investments. The firm facilitates buyouts, growth capital, public-to-private transactions, recapitalizations, and provides debt, shareholder loans, replacement capital, and bridge financing to small and medium-sized enterprises (SMEs). Through its fund of funds strategy, Gimv allocates capital to other venture capital and private equity vehicles. The firm targets high-potential growth companies capable of accelerating their expansion, often through a combination of organic development and strategic acquisitions. Gimv's investment focus is broad, encompassing sectors such as consumer goods and connected consumer technologies, R&D-intensive businesses positively impacting human health and the environment, automation, health and care, demographic shifts, financial services (including consumer digital lending), telecommunication services, marketing services, interactive home entertainment, smart industries, and sustainable urban development. Within its health and care platform, Gimv prioritizes companies poised for growth via internal expansion or a "buy-and-build" acquisition strategy. More specifically, the consumer vertical covers areas like consumer goods, various food categories (including healthy, prepared, and preserved), personal luxury items, home decor and building, household appliances, specialized housewares, travel and leisure, education, and sectors driven by digitalization and the digital economy. In the health and care arena, it targets life sciences, medical technology (medtech), healthcare services, veterinary pharmaceuticals, generic drugs, vaccines, diagnostic testing, and a range of medical devices and consumables. Its Smart Industries platform includes aerospace, energy transition, business-to-business (B2B) services, advanced engineering, and software solutions. The Sustainable Cities platform delves into infrastructure deployment, energy systems, recycling and recovery, transport and logistics, water purification, e-commerce, alternative energy sources, and energy-efficient infrastructure, as well as consumer-related services within these themes. Additionally, Gimv considers investments in building materials (including chemicals, fertilizers, and agricultural chemicals), mobility solutions, operational services, agricultural services, electronics, and heavy electrical equipment. Geographically, Gimv concentrates its efforts primarily within the DACH region (Austria, Germany, Switzerland), the Benelux countries, France, and the United Kingdom. It also has a presence in Italy, Luxembourg, the Netherlands, Russia, Kazakhstan, the Czech Republic, and Slovakia. Its investments target small and medium-sized enterprises (SMEs), predominantly those headquartered in the Benelux, France, and Germany. Investment amounts typically range from €5 million ($5.67 million) to €150 million ($170.22 million), primarily within its consumer, healthcare, smart industries, and sustainable cities platforms. Gimv is flexible regarding ownership, taking either majority or minority stakes in its portfolio companies. Established on February 25, 1980, Gimv N.V. is headquartered in Antwerp, Belgium, and maintains additional offices across Europe, including Paris (France), The Hague (Netherlands), Frankfurt am Main and Munich (Germany), London (United Kingdom), Prague (Czech Republic), and Warsaw (Poland).
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||